日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Three-Year Follow-Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing Cancer-Associated Fibroblast Heterogeneity Corresponding to PD-1 Blockade Efficacy.

局部晚期胃癌和胃食管交界处腺癌新辅助替雷利珠单抗联合化疗三年随访：揭示与 PD-1 阻断疗效相对应的癌症相关成纤维细胞异质性。

期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202508433
Lin Yao, Sun Xiong, Li Chengguo, Yang Ming, Wu Ke, Liu Ke, Li Anshu, Shuai Xiaoming, Cai Kailin, Wang Zheng, Wang Guobin, Zhang Peng, Shen Jianfeng, Tao Kaixiong, Yin Yuping
胃癌
细胞生物学
成纤维细胞
PD-1
发表日期：2026
文献求助 收藏

Cancer-Derived Exosomal LINC01615 Induces M2 Polarization of Tumor-Associated Macrophages via RBMX-EZH2 Axis to Promote Colorectal Cancer Progression

癌症来源的外泌体LINC01615通过RBMX-EZH2轴诱导肿瘤相关巨噬细胞M2极化，从而促进结直肠癌进展

期刊:International Journal of Nanomedicine
影响因子:6.5
doi:10.2147/IJN.S499381
Li, Anshu; Hong, Jiaxin; Ma, Xianxiong; Huang, Yongzhou; Jiang, Qi; Zhang, Chenggang; Wang, Yu; Huang, Yongming
巨噬细胞
外泌体
肿瘤
肠癌
肿瘤免疫
巨噬细胞
BMX
EZH2
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Colorectal cancer stem cells crosstalk in tumor immune microenvironment and targeted therapeutic strategies

结直肠癌干细胞在肿瘤免疫微环境中的相互作用及靶向治疗策略

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1714954
Duan, Yuxuan; Li, Anshu; Miao, Daojia; Tan, Diaoyi; Wang, Keshan; Shi, Jian
肿瘤
肠癌
肿瘤免疫
细胞生物学
干细胞
发育与干细胞
免疫/内分泌
发表日期：2025
文献求助 收藏

Recent progress on tyrosine kinase inhibitors resistance in renal cell carcinoma: another brick in the wall?

肾细胞癌酪氨酸激酶抑制剂耐药性研究的最新进展：又一块砖砌进了这堵墙上？

期刊:Cancer Drug Resistance
影响因子:5.2
doi:10.20517/cdr.2025.157
Dong, Zirui; Li, Shoukang; Li, Mingfeng; Fan, Meiyin; Chen, Kailei; Li, Anshu; Wang, Keshan; Zhang, Xiaoping
肿瘤
肿瘤免疫
信号转导
肾癌
细胞生物学
发表日期：2025
文献求助 收藏

PTOV1 interacts with ZNF449 to promote colorectal cancer development.

PTOV1 与 ZNF449 相互作用，促进结直肠癌的发展

期刊:Communications Biology
影响因子:5.1
doi:10.1038/s42003-025-07930-2
Wang Zhiyong, Qiao Xinwei, Xue Kaming, Chen Qianzhi, Li Anshu
肿瘤
肠癌
发表日期：2025
文献求助 收藏

Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: Early results of a phase 2, single-arm trial

新辅助替雷利珠单抗联合替加氟/吉美嘧啶/奥曲嘧啶（S-1）加奥沙利铂治疗局部晚期胃癌或胃食管交界处癌患者：一项 II 期单臂试验的早期结果

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.959295
Yin, Yuping; Lin, Yao; Yang, Ming; Lv, Jianbo; Liu, Jiaying; Wu, Ke; Liu, Ke; Li, Anshu; Shuai, Xiaoming; Cai, Kailin; Wang, Zheng; Wang, Guobin; Shen, Jianfeng; Zhang, Peng; Tao, Kaixiong
胃癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis

circRNA_101277通过调节miR-370/IL-6轴影响结直肠癌细胞的顺铂耐药性

期刊:Genetics Research
影响因子:2.1
doi:10.1155/2022/4237327
Lv, Qing; Xia, Qinghua; Li, Anshu; Wang, Zhiyong
IL-6
肿瘤
circRNA
肠癌
细胞生物学
肿瘤免疫
发表日期：2022
文献求助 收藏

Prognostic Utility of Platelet-to-Albumin Ratio among Critically Ill Patients with Colorectal Cancer: A Propensity Score Matching Study

血小板/白蛋白比值在重症结直肠癌患者预后中的价值：一项倾向评分匹配研究

期刊:Journal of Oncology
影响因子:
doi:10.1155/2022/6107997
Li, Anshu; Wang, Zhiyong; Lv, Qing; Ling, Yan
血小板
肿瘤
肠癌
肿瘤免疫
发表日期：2022
文献求助 收藏